LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion.
Mori S, Izumi H, Araki M, Liu J, Tanaka Y, Kagawa Y, Sagae Y, Ma B, Isaka Y, Sasakura Y, Kumagai S, Sakae Y, Tanaka K, Shibata Y, Udagawa H, Matsumoto S, Yoh K, Okuno Y, Goto K, Kobayashi SS.
Mori S, et al. Among authors: sakae y.
Commun Biol. 2024 Apr 4;7(1):412. doi: 10.1038/s42003-024-06116-6.
Commun Biol. 2024.
PMID: 38575808
Free PMC article.